A.P. Møller sells Maersk Medical A/S  

Leading Danish med-tech company Maersk Medical is sold to equity fund Nordic Capital for an undisclosed sum

A.P. Møller has signed a definitive agreement to divest its subsidiary Maersk Medical A/S to Nordic Capital for an undisclosed sum. The transaction is subject to governmental approval, which is expected in the next couple of months. Nordic Capital, one of the largest equity funds in the Nordic region, intends to continue to develop the company's business. The news is reported on the Copenhagen Stock Exchange website.


Maersk Medical is one of Denmark’s leading med-tech companies. It develops, produces and markets sterile single-use medical devices to the health care sector. Maersk Medical employs 4,500 people worldwide and has production facilities in Denmark, UK, Belarus, Malaysia, Singapore, Australia and Mexico. The company sells its products worldwide through sales companies in 12 countries including the US, and through independent distributors in all other major markets. Total turnover for 2002 is expected to reach approx. DKK 1.9 billion (USD 247 million).

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×